WuXi Biologics (Cayman) Inc
OTC:WXIBF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
WuXi Biologics (Cayman) Inc
OTC:WXIBF
|
CN |
|
T
|
Technogym SpA
XBER:TN2
|
IT |
|
I
|
ITM Power PLC
OTC:ITMPF
|
UK |
|
Brookfield Business Corp
F:C6E
|
US |
|
E
|
Edison International
DUS:EIX
|
US |
|
G
|
Genesis AI Corp
OTC:AIGFF
|
CA |
|
Telenor ASA
OSE:TEL
|
NO |
|
Genmab A/S
CSE:GMAB
|
DK |
|
M
|
Melia Hotels International SA
SWB:MEL
|
ES |
|
A
|
Aptiv PLC
XMUN:D7A
|
IE |
|
Cosan SA
F:9CI0
|
BR |
|
Century Lithium Corp
F:C1Z
|
CA |
|
D
|
Deoleo SA
XBER:SC5A
|
ES |
Wall St Price Targets
WXIBF Price Targets Summary
WuXi Biologics (Cayman) Inc
According to Wall Street analysts, the average 1-year price target for WXIBF is 5.44 USD with a low forecast of 3.61 USD and a high forecast of 9.71 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is WXIBF's stock price target?
Price Target
5.44
USD
According to Wall Street analysts, the average 1-year price target for WXIBF is 5.44 USD with a low forecast of 3.61 USD and a high forecast of 9.71 USD.
What is the Revenue forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%
Over the last 10 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 49%. The projected CAGR for the next 8 years is 11%.
What is the Operating Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
15%
Over the last 10 years, the compound annual growth rate for Operating Income has been 60%. The projected CAGR for the next 8 years is 15%.
What is the Pre-Tax Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
18%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 60%. The projected CAGR for the next 3 years is 18%.
What is the Net Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
13%
Over the last 10 years, the compound annual growth rate for Net Income has been 60%. The projected CAGR for the next 8 years is 13%.
